You are here

  • Home
  • Archive
  • Volume 82, Issue 5
  • Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry’

Article Text

Article menu

This article has a Reply. Please see:

Download PDFPDF
Correspondence
Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry’
  1. Laurent Arnaud1,2,
  2. Hervé Devilliers3,4
  1. 1 Department of Rheumatology, Hôpitaux universitaires de Strasbourg, Strasbourg, France
  2. 2 Centre National de Référence des Maladies Auto-immunes et Systémiques (CRMR RESO), Strasbourg, France
  3. 3 Internal Medicine and Systemic Diseases, Hôpital François Mitterrand, CHU de Dijon, Dijon, France
  4. 4 Clinical Epidemiology Unit, INSERM, CIC 1432, Dijon, France
  1. Correspondence to Professor Laurent Arnaud, Department of Rheumatology, Hôpitaux universitaires de Strasbourg, 67091 Strasbourg, Alsace, France; laurent.arnaud{at}chru-strasbourg.fr

http://dx.doi.org/10.1136/annrheumdis-2021-220037

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read with great interest the recent paper “Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry” published in the Annals by Strangfeld et al.1

    Given the current epidemiological situation, all evidence indicate that the best option for preventing both morbidity and mortality in the initial phase of the COVID-19 vaccination programme is to directly protect persons who are most at risk. Based on the author’s findings,1 and previously published data,2 not all patients with rheumatic disease are at increased risk of severe COVID-19 and …

    View Full Text

    Footnotes

    • Twitter @Lupusreference

    • Contributors LA and HD wrote the manuscript and approved the final version.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles